GN
Genelux
GNLX·NASDAQSan Diego CAFounded 200140 employees
Micro CapbiotechPublicOncology
Platform: Olvimulogene GL-ONC1
Market Cap
$0.04B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (GNLX)
Loading GNLX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Teraglumide | GNL-9828 | Phase 2 | 1 | BCMA | ADHDNarcolepsy | ||
| GNL-2086 | GNL-2086 | Preclinical | 1 | CD3 | ThymomaGastric Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (1)